Los Angeles Project
Austin, US · Founded 2023 · Delaware corporation · 2 known investors
Building.life uses genetic engineering, genomic analysis, and AI to design novel organisms, beginning with engineering the world's first true unicorn through precision gene editing and embryonic development.
Founders & leadership
Los Angeles Project was founded in 2023 by Josie Zayner PhD and Josette Zayner.
JZ
Josie Zayner PhDFounder
JZ
Josette ZaynerCo-founder
Investors · 2
Reported raises · per SEC filings
Form D private placements$7.8M disclosed across 5 rounds · 2023–2026
▶$4.9MraisedJun 2026 · 13 investors · BiotechnologyRule 506(b)
▶$4.9MraisedJun 2026 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Josette ZaynerExecutive Officer, Director
- Offering amount
- $6.9M
- Amount sold
- $4.9M
- First sale
- May 2026
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
▶$1.5MraisedJun 2026 · 5 investors · BiotechnologyRule 506(b)
▶$1.5MraisedJun 2026 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Josette ZaynerExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- First sale
- Nov 2024
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
▶$79.1KraisedJun 2026 · 1 investors · BiotechnologyRule 506(b)
▶$79.1KraisedJun 2026 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Josette ZaynerExecutive Officer, Director
- Offering amount
- $79.1K
- Amount sold
- $79.1K
- First sale
- Jan 2026
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
▶$730KraisedJun 2026 · 4 investors · BiotechnologyRule 506(b)
▶$730KraisedJun 2026 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Josette ZaynerExecutive Officer, Director
- Offering amount
- $730K
- Amount sold
- $730K
- First sale
- Oct 2023
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
▶$625KraisedJun 2026 · 4 investors · BiotechnologyRule 506(b)
▶$625KraisedJun 2026 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Josette ZaynerExecutive Officer, Director
- Offering amount
- $625K
- Amount sold
- $625K
- First sale
- Jun 2024
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlapSimbryotech4 shared keywordsSimbryo Technologies is a biotech company that creates endometrial organoids from a patient's own stem cells using a routine biopsy, offering functional diagnostic tests of the uterine lining to assess and optimize endometrial fertility. Working with research institutions and fertility clinics, it uses organoid medicine and AI to give patients and physicians insights aimed at improving IVF success rates and to serve as a test bed for new fertility treatments.
Conception3 shared keywordsConception develops stem cell technology to create functional reproductive cells in the laboratory, enabling in-vitro gametogenesis as a solution for individuals facing biological and medical fertility barriers.
Companies competing with Los Angeles Project for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Los Angeles Project do?
- Building.life uses genetic engineering, genomic analysis, and AI to design novel organisms, beginning with engineering the world's first true unicorn through precision gene editing and embryonic development.
- Who founded Los Angeles Project?
- Los Angeles Project was founded by Josie Zayner PhD, Josette Zayner in 2023.
- Who are Los Angeles Project's investors?
- Los Angeles Project's investors include Compound, Draper Associates.
- How much funding has Los Angeles Project raised?
- Los Angeles Project has disclosed $7.8M raised across 5 rounds.
- Where is Los Angeles Project headquartered?
- Los Angeles Project is headquartered in Austin, US.